Johannes vom Berg

Company: InCephalo

Job title: CSO

Seminars:

Exclusive Modulation of the Glioma TME with InC01, InCephalo’s Compartment Locked IL-12 11:45 am

InCephalo’s compartment lock (C-Lock) technology enables high local CNS levels at minimal systemic exposure for antibodies or Fc-fusion constructs Preclinical data on the development of InC01, a C-Locked IL-12-based biologic and proof of concept data in relevant murine and human ex vivo models will be presented InC01 shows excellent tolerability, synergizes not only with immune…Read more

day: Conference Day 1